Alcohol also damages the liver by allowing bacteria to infiltrate

"Alcohol appears to impair the body's ability to keep microbes in check," said senior author Bernd Schnabl, MD, associate professor of gastroenterology at UC San Diego School of Medicine. "When those barriers breakdown, bacteria that don't normally colonize the liver end up there, and now we've found that this bacterial migration promotes alcohol liver disease. Strategies to restore the body's defenses might help us treat the disease."

Schnabl and team previously found that chronic alcohol consumption is associated with lower intestinal levels of REG3 lectins, which are naturally occurring antimicrobials.

In their current study, the researchers discovered that REG3G deficiency promotes progression of alcohol-induced liver disease. Mice engineered to lack REG3G and fed alcohol for eight weeks were more susceptible to bacterial migration from the gut to the liver than normal mice who received the same amount of alcohol. REG3G-deficient mice also developed more severe alcoholic liver disease than normal mice.

To find methods for stemming the tide of liver-damaging microbes, Schnabl and team tried experimentally bumping up copies of the REG3G gene in intestinal lining cells grown in the lab. They found that more REG3G reduced bacterial growth. Likewise, restoring REG3G in mice protected them from alcohol-induced fatty liver disease, a condition that precedes end-stage cirrhosis.

Human small intestine samples supported some of the team's finding in mice. Not only do patients with alcohol dependency have lower levels of REG3G than healthy people, they also have more bacteria growing there.

Liver cirrhosis, or end-stage liver disease, is the 10th leading cause of death in the United States, and approximately half of these deaths are related to alcohol consumption.

Study co-authors include Lirui Wang, Cristina Llorente, Samuel B. Ho, UC San Diego and Veterans Affairs San Diego Healthcare System; Derrick E. Fouts, Jessica DePew, Kelvin Moncera, J. Craig Venter Institute; Peter Stärkel, St. Luc University Hospital; Phillipp Hartmann, Peng Chen, David A. Brenner, UC San Diego; Lora V. Hooper, University of Texas Southwestern Medical Center and Howard Hughes Medical Institute. 10.1016/j.chom.2016.01.003

This research was funded, in part, by the National Institutes of Health (K08 DK081830, R01 AA020703, U01 AA021856, P30 NS047101) and VA Office of Research and Development.